Woo Ri Shin

Title: Woo Ri Shin: Innovator in Skin Treatment Technologies

Introduction

Woo Ri Shin is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of skin treatment through his innovative research and development. His work focuses on enhancing the effectiveness of therapeutic agents for skin conditions.

Latest Patents

Woo Ri Shin holds a patent for a "Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients." This invention pertains to a botulinum toxin, epithelial cell growth factor, or hexapeptide fusion protein that is bound to skin tissues and cell-permeable peptides. The composition aims to improve skin conditions, treat wrinkles, relieve muscle tension, and aid in wound healing. The fusion protein or epithelial cell growth factor mixed with cell-permeable peptides demonstrates increased cell permeability compared to the protein alone, making it a valuable advancement in dermatological treatments.

Career Highlights

Woo Ri Shin is currently employed at Avixgen Inc., where he continues to develop innovative solutions for skin health. His expertise in the field has positioned him as a key player in the research and development of effective skin treatment technologies.

Collaborations

He collaborates with talented coworkers, including Yi Yong Baek and Si Eun Park, to further enhance the impact of their research and innovations in the industry.

Conclusion

Woo Ri Shin's contributions to skin treatment technologies through his patented innovations highlight his role as a leading inventor in the field. His work not only advances scientific understanding but also offers practical solutions for improving skin health.